Perspective Therapeutics ...

1.95
-0.18 (-8.45%)
At close: Apr 01, 2025, 3:59 PM
2.06
5.70%
After-hours: Apr 01, 2025, 08:00 PM EDT

Perspective Therapeutics Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
PE Ratio -2.31 -23.93 -61.34 -259.93 -114.98 -56.67 -37.05 -55.8 -101.6 -220.66
PEG Ratio -0.00 -0.24 -0.96 7.11 3.48 1.43 -4.08 -1.96 -3.69 4.24
PS Ratio 75.03 49.41 40.64 82.43 38.83 37.58 41.91 72.22 100.36 176.33
PB Ratio 1.43 6.42 7.16 12.29 65.68 35.79 49.35 32.43 29.18 39.08
P/FCF Ratio -2.83 -28.14 -55.01 -257.51 -96.03 -50.04 -41.03 -54.92 -109.38 -221.14
P/OCF Ratio -2.91 -28.84 -56.91 -292.09 -103.23 -54.44 -43.46 -60.2 -123.23 -230.63
OCF/S Ratio -25.74 -1.71 -0.71 -0.28 -0.38 -0.69 -0.96 -1.2 -0.81 -0.76
Debt / Equity Ratio 0.03 n/a 0.01 0.01 0.18 n/a n/a n/a n/a n/a
Quick Ratio 1.07 19.36 25.57 36.83 3.09 6.05 2.70 9.01 12.16 14.58
Current Ratio 1.07 19.89 26.18 37.37 3.50 6.53 2.98 9.30 12.47 14.95
Asset Turnover 0.01 0.12 0.17 0.14 1.11 0.78 0.79 0.39 0.26 0.20
Interest Coverage -487.39 n/a -62.11 n/a n/a n/a n/a n/a -5.35K -1.96K
Return on Equity (ROE) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Assets (ROA) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Return on Capital (ROIC) n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Yield n/a n/a n/a 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratio n/a n/a n/a -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Gross Profit Margin 100.00% 23.00% 42.76% 50.94% 52.93% 0.42% 0.31% 0.18% 0.03% 0.04%
Net Profit Margin -3.24K% -206.5% -66.26% -31.71% -33.77% -0.66% -1.13% -1.29% -0.99% -0.8%
Pretax Profit Margin -2.8K% -206.5% -67.36% -33.69% -35.6% -0.7% -1.13% -1.29% -0.99% -0.8%
Operating Profit Margin -2.86K% -213.71% -68.47% -34.19% -35.91% -0.72% -1.14% -1.32% -1.07% -0.94%
FCF Margin -2.65K% -175.59% -73.89% -32.01% -40.43% n/a n/a n/a n/a n/a
EBITDA Margin -2.79K% -208.87% -68.47% -34.1% -35.91% -0.72% -1.13% -1.3% -0.92% -0.88%